Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Microbiome

Jose U. Scher, MD, Steven B. Abramson, MD  |  Issue: November 2011  |  November 1, 2011

Abbreviations: PCR, polymerase chain reaction; rRNA, ribosomal RNA.

Source: Nat Rev Rheumatol. 2011;7:569-578. Reproduced with permission of Nature Pub. Group.

To assess the microbiome, a highly conserved gene found in all species of bacteria and archaea—the 16S ribosomal RNA (16S rRNA) gene, or 16S—can be targeted, amplified, and utilized for phylogenetic studies.11 Since the gene is specific to bacteria and simultaneously contains hypervariable regions, sequencing 16S permits not only its separation from other prokaryotic and eukaryotic cells within a given sample, but also an unbiased taxonomic tool to differentiate bacterial species among themselves. Next-generation sequencing platforms, such as 454, Illumina, and others, allow for bar-coded, massively parallel 16S rRNA sequencing of millions of sequence determinations in a single experiment. If, a decade ago, the isolation and identification of a given species took months to achieve, dozens of samples containing thousands of different species each can now be sequenced and classified in one day. But this approach only helps with the question of “Who is there?”—in other words, what is the community microbial composition in terms of relative abundance?

To address an even more complex matter (“What are the microbes doing?”), it is now feasible to perform whole-genome shotgun sequencing of a given microbiome (metagenome). Using the same sequencing platforms as in 16S surveys, we also can elucidate the vast array of enzymatic and metabolic pathways generated by these communities, and, with these data, begin to understand their function and behavior. Multiple studies have found that a significant number of intestinal microbiome genes are simply not encoded by the human genome. Among these are genes whose products are essential for the biological development and well-being of humans, including enzymes involved in metabolism of otherwise indigestible polysaccharides, amino acids, and xenobiotics, and the production of proteins associated with the maturation and regulation of the immune system. Concomitantly, an enormous computational biology (and biologist) capacity, along with sophisticated bioinformatic tools and true multidisciplinary efforts are required to filter, align, assemble, and annotate the colossal amount of data and metadata generated and make scientific sense of it.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Microbiome and the Host Response

More than a thousand bacterial species inhabit our intestinal tract.3 Humans and most mammals in the animal kingdom develop all vital organs and mature under strict sterile conditions, protected by the uterine cavity. Indeed, perturbation by any microorganism often can lead to embryonic malformation or death. Immediately after birth, biologic chaos ensues. Vaginal or skin bacteria (depending on delivery mode) engraft the newborn’s intestines and other body surfaces. Throughout the first year of life, species richness and diversity is rather variable. However, with the introduction of solid foods at the end of this period, the gut microbiota expands, stabilizes, and adopts the complexity of the adult communities.12

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:bacteriaMicrobiomePathogenesisRAResearchRheumatoid arthritis

Related Articles
    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA

    March 18, 2019

    A growing body of research is elucidating the role of intestinal microbiota in several auto­immune diseases, including rheumatoid arthritis (RA). Research published in December 2018 Arthritis & Rheumatology increases our understanding of the “extent and nature of mucosal immune activation during preclinical arthritis.”1 The research objective, according to the report, was to “dissect intestinal mucosal immune…

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences